Shares of China Cord Blood Corp. (NYSE:CO) dropped 2.9% on Wednesday . The stock traded as low as $5.56 and last traded at $5.61, with a volume of 79,362 shares trading hands. The stock had previously closed at $5.78.

Separately, Zacks Investment Research cut shares of China Cord Blood Corp. from a “buy” rating to a “hold” rating in a report on Monday, March 21st. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $8.33.

The firm has a 50 day moving average price of $5.92 and a 200-day moving average price of $6.04. The company has a market cap of $409.55 million and a P/E ratio of 30.00.

China Cord Blood Corp. (NYSE:CO) last posted its quarterly earnings data on Tuesday, June 14th. The company reported $0.03 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.03. The company had revenue of $24.30 million for the quarter. Equities analysts expect that China Cord Blood Corp. will post $0.17 EPS for the current year.

China Cord Blood Corporation is principally engaged in the provision of umbilical cord blood storage and ancillary services in the People’s Republic of China. The Company provides cord blood testing, processing and storage services under the direction of subscribers. The Company also preserves cord blood units donated by the public, provides matching services on such donated units and delivers matching units to patients in need of transplants.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.